Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

Author:

Norhammar Anna,Bodegård Johan,Nyström Thomas,Thuresson Marcus,Eriksson Jan W.,Nathanson David

Funder

This study was sponsored by AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. IDF (2014) IDF diabetes atlas. Available from www.diabetesatlas.org , accessed 12 December 2015

2. WHO (2014) Global status report on noncommunicable diseases. Available from apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua = 1, accessed 5 December 2015

3. Grover SA, Kaouache M, Rempel P et al (2015) Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study. Lancet Diabetes Endocrinol 3:114–122

4. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ (2014) Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes Endocrinol 2:867–874

5. Public Health Agency of Sweden (2014) Folkhälsan i Sverige. Available from www.folkhalsomyndigheten.se/pagefiles/17825/Folkhalsan-i-Sverige-arsrapport-2014.pdf [article in Swedish], accessed 1 November 2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3